| The platelet count and its implications in sickle cell disease patients admitted for intensive care DK Shome, A Jaradat, AI Mahozi, AS Sinan, A Ebrahim, M Alrahim, ... Indian Journal of Critical Care Medicine: Peer-reviewed, Official …, 2018 | 21 | 2018 |
| Trajectory of symptoms in patients undergoing autologous stem cell transplant for multiple myeloma: a population-based cohort study of patient-reported outcomes MS Ebraheem, H Seow, AK Balitsky, GR Pond, TM Wildes, ... Clinical Lymphoma Myeloma and Leukemia 21 (9), e714-e721, 2021 | 13 | 2021 |
| Extended DOAC therapy in patients with VTE and potential risk of recurrence: A systematic review and meta‐analysis M Ebraheem, I Alzahrani, M Crowther, B Rochwerg, M Almakadi Journal of Thrombosis and Haemostasis 18 (9), 2308-2317, 2020 | 12 | 2020 |
| Extended venous thromboembolism prophylaxis after abdominopelvic cancer surgery: a retrospective review M Laureano, M Ebraheem, M Crowther Current Oncology 26 (1), 106-110, 2019 | 9 | 2019 |
| Deepening responses after upfront autologous stem cell transplantation in patients with newly diagnosed multiple myeloma in the era of novel agent induction therapy M Ebraheem, SK Kumar, A Dispenzieri, D Jevremovic, FK Buadi, D Dingli, ... Transplantation and Cellular Therapy 28 (11), 760. e1-760. e5, 2022 | 3 | 2022 |
| Treatment and outcomes of patients with light chain amyloidosis who received a second line of therapy post autologous stem cell transplantation AS Al Saleh, MS Ebraheem, MH Sidiqi, A Dispenzieri, E Muchtar, ... Blood cancer journal 12 (4), 59, 2022 | 3 | 2022 |
| Stuttering priapism in a patient with sickle cell trait treated with automated red cell exchange transfusion MS Ebraheem, M Verhovsek Blood Advances 5 (23), 5020-5022, 2021 | 2 | 2021 |
| Treatment Pattern, Healthcare Resource Utilization and Symptom Burden Among Patients with Triple Class Exposed Multiple Myeloma: A Population-Based Cohort Study H Mian, H Seow, GR Pond, A Gayowsky, R Foley, A Balistky, M Ebraheem, ... Clinical Lymphoma Myeloma and Leukemia, 2024 | | 2024 |
| Treatment Patterns and Healthcare Resource Utilization Among Patients with Triple Class Exposed Multiple Myeloma: A Population-Based Cohort Study A Visram, H Seow, G Pond, A Gayowsky, A McCurdy, C Cipkar, H Sapru, ... Blood 142, 3774, 2023 | | 2023 |
| Risk of cancer-specific death among octogenarians with multiple myeloma: A population-based analysis J Britto, H Seow, GR Pond, TM Wildes, A McCurdy, A Visram, ... Journal of Geriatric Oncology 14 (8), 101592, 2023 | | 2023 |
| Immunoglobulin Heavy Chain Amyloidosis: Patient Characteristics and Outcomes MS Ebraheem, E Muchtar, SK Kumar, A Dispenzieri, FK Buadi, D Dingli, ... Blood 140 (Supplement 1), 8092-8093, 2022 | | 2022 |
| Deepening responses post upfront ASCT in newly diagnosed multiple myeloma in the era of novel agent induction therapy M Ebraheem, SK Kumar, A Dispenzieri, D Jevremovic, FK Buadi, D Dingli, ... Transplantation and cellular therapy 28 (11), 760. e1, 2022 | | 2022 |
| P908: FACTORS ASSOCIATED WITH THE CLINICAL PROGNOSTIC PERFORMANCE OF MINIMAL RESIDUAL DISEASE ASSESSMENT BY NEXT GENERATION FLOW CYTOMETRY IN MULTIPLE MYELOMA B Nandakumar, A Baranwal, M Ebraheem, H Olteanu, M Shi, S Kumar, ... HemaSphere 6, 799-800, 2022 | | 2022 |
| Impact of high-dose melphalan followed by autologous stem cell transplant in producing MRD negative complete response in newly diagnosed multiple myeloma. M Ebraheem, J Cook, S Kumar, D Jevremovic, A Dispenzieri, D Dingli, ... Journal of Clinical Oncology 40 (16_suppl), e20001-e20001, 2022 | | 2022 |
